Hydroxyzine has not been proven effective for anxiety beyond four months of continuous use. That’s the specific cutoff noted in FDA-approved labeling, which states that no systematic clinical studies have evaluated the drug’s usefulness as an anti-anxiety medication past that point. For itching and allergy-related uses, no firm duration limit exists, but safety reviews increasingly recommend keeping treatment “as short as possible” regardless of the reason you’re taking it.
That doesn’t mean hydroxyzine becomes dangerous on day 121. It means the evidence supporting its benefits gets thinner the longer you take it, while the risks quietly accumulate.
What the Four-Month Benchmark Means
The four-month figure comes directly from the drug’s FDA labeling, which instructs prescribers to “reassess periodically the usefulness of the drug for the individual patient” beyond that window. This isn’t a hard stop. It’s a signal that hydroxyzine was studied and approved as a shorter-term tool, not a medication you stay on indefinitely the way you might with an SSRI or SNRI.
Clinical guidelines reflect this positioning. A 2025 treatment algorithm from Singapore’s Agency for Care Effectiveness recommends hydroxyzine for mild generalized anxiety disorder only with a plan to transition to cognitive behavioral therapy or a longer-term medication like an SSRI if it’s not enough. Oregon Health Authority guidelines note that while hydroxyzine can be as effective as other anxiety medications, “sedation, anticholinergic effects, and limited clinical experience are barriers to long-term use.” In practice, hydroxyzine works best as a bridge: something to take the edge off while a longer-term strategy gets established.
Heart Rhythm Concerns With Extended Use
Health Canada conducted a safety review after the European Medicines Agency flagged a potential link between hydroxyzine and changes in the heart’s electrical activity. The review confirmed that hydroxyzine can contribute to a condition called QT prolongation, where the heart takes longer than normal to recharge between beats. In rare cases, this leads to dangerous irregular rhythms.
A clinical study found measurable QT prolongation after a single 100 mg dose, and the risk climbs with higher doses and longer exposure. Most reported cases involved patients who had additional risk factors: other medications that affect heart rhythm, electrolyte imbalances, a family history of heart conditions, or daily doses over 100 mg. But the finding prompted regulators to push for labeling changes recommending the shortest possible treatment duration.
The Anticholinergic Burden Over Time
Hydroxyzine is a strong anticholinergic, meaning it blocks a chemical messenger involved in memory, digestion, and other body functions. On the Anticholinergic Cognitive Burden Scale used by researchers at Indiana University, hydroxyzine scores a 3 out of 3, the highest possible rating. Drugs at that level carry evidence that they can cause confusion and delirium.
The concern isn’t just short-term fogginess. Research tied to that scale found that each “definite anticholinergic” medication (score of 2 or 3) may increase the risk of cognitive impairment by 46% over six years. Each one-point increase in a person’s total anticholinergic burden was also correlated with a 26% increase in mortality risk. These numbers come from population-level studies, so individual risk varies, but they illustrate why cumulative exposure matters. The longer you take hydroxyzine, and the more anticholinergic medications you’re on simultaneously, the steeper the curve.
This is especially relevant if you take other medications with anticholinergic properties, which include many common allergy drugs, sleep aids, bladder medications, and certain antidepressants. The effects stack.
Specific Risks for Adults Over 65
The American Geriatrics Society’s 2023 Beers Criteria, the most widely used guide for identifying medications that pose extra risks in older adults, lists hydroxyzine with a one-word recommendation: “Avoid.” The strength of that recommendation is rated “strong,” based on moderate-quality evidence.
The rationale is straightforward. Older adults clear hydroxyzine from their bodies more slowly, so the drug lingers longer and hits harder. The anticholinergic effects that might cause mild dry mouth or drowsiness in a 30-year-old can trigger confusion, falls, constipation, and delirium in someone over 65. The Beers Criteria also notes that tolerance develops quickly when hydroxyzine is used as a sleep aid, meaning it stops working for that purpose while the side effects persist. The guidance adds that cumulative anticholinergic exposure raises fall, delirium, and dementia risk “even in younger adults,” urging caution across age groups.
What Happens When You Stop
Hydroxyzine is not considered addictive in the way benzodiazepines are, but your body does adjust to its presence. Stopping abruptly after regular use can produce withdrawal-like effects, most commonly disrupted sleep, even if you weren’t taking it for insomnia. Rebound symptoms are also common: anxiety or itching that temporarily feels worse than it did before you started the medication.
If you were using hydroxyzine for allergies or hives, stopping can trigger a temporary spike in itching. This happens because your histamine receptors have been suppressed by the drug. When the suppression lifts, histamine activity can temporarily overshoot its baseline before settling back to normal. This rebound effect is uncomfortable but typically short-lived.
Tapering gradually rather than stopping all at once reduces the intensity of these effects. There’s no standard tapering schedule for hydroxyzine, so the pace depends on how long you’ve been taking it and at what dose.
Practical Timelines by Use
How long hydroxyzine makes sense depends on what you’re taking it for:
- Anxiety: Most useful in the first few weeks to months while a longer-term treatment plan takes hold. The evidence base runs out at four months, and clinical guidelines treat it as a bridge, not a destination. If you’ve been on it longer than that and it’s your only anxiety treatment, it’s worth revisiting the plan.
- Itching and hives: Often used in short courses during flare-ups. There’s no strict time limit for this indication, but the heart rhythm and anticholinergic concerns still apply with extended use. Keeping doses at or below 50 mg per day and limiting duration when possible reduces risk.
- Sleep: Tolerance builds quickly, which means it loses effectiveness for insomnia faster than for other uses. Continuing it past the point where it stops helping with sleep means you’re absorbing side effects without getting benefits.
The daily dosage ceiling for adults with anxiety is 400 mg (100 mg taken four times daily), though doses above 100 mg per day carry meaningfully higher heart rhythm risk. For itching, the typical adult dose is 25 mg taken three or four times daily. These are upper limits, not targets. Most people are prescribed well below them.